Kayne Anderson Rudnick Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.11M | Buy |
|
|||||
|
2025
Q4 | $1.16M | Sell |
|
|||||
|
2025
Q3 | $1.87M | Buy |
|
|||||
|
2025
Q2 | $1.59M | Sell |
|
|||||
|
2025
Q1 | $1.69M | Sell |
|
|||||
|
2024
Q4 | $2.22M | Sell |
|
|||||
|
2024
Q3 | $3.18M | Sell |
|
|||||
|
2024
Q2 | $5.23M | Sell |
|
|||||
|
2024
Q1 | $5.68M | Sell |
|
|||||
|
2023
Q4 | $5.32M | Buy |
|
|||||
|
2023
Q3 | $4.34M | Sell |
|
|||||
|
2023
Q2 | $4.28M | Buy |
|
|||||
|
2023
Q1 | $4M | Buy |
|
|||||
|
2022
Q4 | $2.8M | Buy |
|
|||||
|
2022
Q3 | $1.69M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $5K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $3.43M | Sell |
|
|||||
|
2016
Q1 | $3.52M | Buy |
|
|||||
|
2015
Q4 | $2.4M | Buy |
|
|||||
|
2015
Q3 | $1.42M | Buy |
|
|||||
|
2015
Q2 | $203K | Buy |
|